Participations à des congrès et colloques internationaux (137)
  1. 78. Pilcer, G., & Amighi, K. (2010). Highly dispersive tobramycin dry powder formulations for inhalation. Poster présenté à la conférence 7th World Meeting on Pharmaceutics Biopharmaceutics and Pharmaceutical Technology (8-11 March 2010: La Valletta, Malta,).
  2. 79. Wauthoz, N., & Amighi, K. (2010). In vivo assessment of temozolomide delivery systems for inhalation therapy of lung cancer. Paper session presented at 7th World Meeting on Pharmaceutics Biopharmaceutics and Pharmaceutical Technology (8-11 March 2010: La Valletta, Malta).
  3. 80. Amighi, K., & Goole, J. (2010). Potential application of gastro-retentive dosage forms in the treatment of Parkinson disease. Paper session presented at European Modified Release Forum (21-22 Avril 2010: Londres, UK).
  4. 81. Wauthoz, N., Deleuze, P., Hecq, J., Roland, I., Saussez, S., Adanja, I., Debeir, O., Decaestecker, C., Mathieu, V., Kiss, R., & Amighi, K. (2009). In vivo assessment of temozolomide delivery systems for inhalation therapy of lung cancer. Paper session presented at Journée doctorale Pôle Santé (17/12/2009: Campus Erasme).
  5. 82. Depreter, F., & Amighi, K. (2009). Formulation and characterisation of lipid-coated insulin dry particles for lung administration. Paper session presented at 14th Forum of Pharmaceutical Sciences (14: 15/05/2009: Blankenberge, Belgium).
  6. 83. Pilcer, G., Goole, J., Van Gansbeke, B., bloklet, D., Knoop, C., Vanderbist, F., & Amighi, K. (2009). In vivo evaluation of new tobramycin dry powder formulations in cystic fibrosis patients. Poster présenté à la conférence 9ième journée des doctorants.
  7. 84. Pilcer, G., Vanderbist, F., & Amighi, K. (2009). New highly dispersive carrier-free dry powder formulations for inhalation. Poster présenté à la conférence 36th Meeting and Annual Exposition of the Controlled Release Society (18-22 July 2009: Copenhagen, Denmark).
  8. 85. Pilcer, G., Vanderbist, F., & Amighi, K. (2008). Development and evaluation of the use of nanoparticles for dry powder inhalation. Poster présenté à la conférence 6th World Meeting on Pharmaceutics Biopharmaceutics and Pharmaceutical Technology (7-10 April 2008: Barcelona, Spain).
  9. 86. Delporte, C., Van Antwerpen, P., Pilcer, G., Wauthoz, N., Zouaoui Boudjeltia, K., Moguilevsky, N., Amighi, K., Kauffmann, J.-M., & Neve, J. (2008). Liposomes as a model of phospholipid membrane surfaces in the study of the role of myeloperoxidase in atherogenesis. Poster présenté à la conférence 6th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (Barcelona).
  10. 87. Depreter, F., & Amighi, K. (2008). Use of Solid Lipid microParticles (SLmP) for the pulmonary delivery of insulin. Paper session presented at Ph.D. students in Pharmaceutical Sciences Day (20/05/2008: Brussels, Belgium).
  11. 88. Goole, J., Deleuze, P., Vanderbist, F., & Amighi, K. (2008). Development of new L-Dopa sustained-release multiple-unit floating system coated with insoluble acrylic polymer. 6th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology Abstract session presented at (Barcelona)
  12. 89. Goole, J., Deleuze, P., Vanderbist, F., & Amighi, K. (2008). Development of new L-Dopa sustained release multiple-unit floating system coated with insoluble acrylic polymer. Poster présenté à la conférence 6th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology.
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 Suivant >>